Physician

Daniel J Krause, DO

According to 2025 Medicare claims, Daniel Krause, DO (NPI: 1457768327) practices internal medicine in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is ASPIRUS MEDICAL GROUP, INC. (NPI: 1033411822; TIN: 391670223) and primary practice location at 54401-4173.

Krause's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,768 traditional Medicare patients, billed 4,076 HCPCS/CPT codes, and received $232,126 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 5,545 prescription claims across 930 beneficiaries totaling $1,286,220 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 7 records totaling $27,669. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $567 to $1,286,220. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$116K$232K2022 Medicare payment: $37,298 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $162,141 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $232,126 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022265457$37,298
20231,0742,199$162,141
20241,7684,076$232,126

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$643K$1.3M2016 Drug cost: $567 (USD; Tot_Drug_Cst)2017 Drug cost: $3,841 (USD; Tot_Drug_Cst)2018 Drug cost: $5,493 (USD; Tot_Drug_Cst)2019 Drug cost: $7,399 (USD; Tot_Drug_Cst)2020 Drug cost: $2,632 (USD; Tot_Drug_Cst)2021 Drug cost: $19,290 (USD; Tot_Drug_Cst)2022 Drug cost: $72,930 (USD; Tot_Drug_Cst)2023 Drug cost: $462,146 (USD; Tot_Drug_Cst)2024 Drug cost: $1,286,220 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R32$567
201722124$3,841
201833121$5,493
201941151$7,399
20201121$2,632
202127132$19,290
2022170547$72,930
20236102,923$462,146
20249305,545$1,286,220

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
78452Nuclear medicine studies of heart muscle at rest and with stress and spect158158$253
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more312391$79
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function775783$52
93308Ultrasound of heart, follow-up194201$26
93018Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician196196$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban37821,360$407,909
VyndamaxTafamidis11330$254,167
EntrestoSacubitril/Valsartan1147,377$155,494
JardianceEmpagliflozin1697,463$142,478
XareltoRivaroxaban1066,762$121,602

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$485Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$27,184Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel J. Krause, DO?

Tedicare shows public-source Medicare data for Daniel J. Krause, DO (NPI 1457768327), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel J. Krause, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel J. Krause, DO?

Daniel J. Krause, DO is linked to ASPIRUS MEDICAL GROUP, INC. (billing NPI 1033411822) in the available physician profile data.

Does Daniel J. Krause, DO have Open Payments data?

Daniel J. Krause, DO has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.